How Healthcare Marketers Are Experimenting Beyond Traditional Media

For years, healthcare media strategies have relied on a familiar playbook: clinical journals, point-of-care platforms, professional portals, and tightly controlled programmatic buys. In a highly regulated industry, these environments have offered safety, control, and predictability. But predictability isn’t the same as effectiveness anymore.

• Read more about How Healthcare Marketers Are Experimenting Beyond Traditional Media

What Is Coupon Settlement? A Complete Guide for CPG Brands

Coupon settlement is the process of reimbursing retailers after a manufacturer-issued coupon is redeemed. For CPG brands, it’s a critical process that ensures promotions drive meaningful shopper engagement and deliver measurable brand and sales impact.

• Read more about What Is Coupon Settlement? A Complete Guide for CPG Brands

Retail Media Confessions, Episode 2: Rethinking ROAS

Retail media is built on measurement—but not all metrics drive the outcomes brands actually need. As investment grows, so does the pressure to prove performance, and too often that performance is reduced to a single number: ROAS.

• Read more about Retail Media Confessions, Episode 2: Rethinking ROAS

Serialization in Pharmaceutical Returns Is Creating New Expectations

Serialization has reshaped how pharmaceuticals move through the supply chain. Much of the attention has focused on outbound distribution and regulatory compliance, but returns are increasingly part of the picture as well.

• Read more about Serialization in Pharmaceutical Returns Is Creating New Expectations

Why Pharmaceutical Returns Policies Are Becoming More Complex

Pharmaceutical returns have never been simple, but the rules that govern them are becoming more complicated each year. What once relied on a relatively small set of manufacturer guidelines has expanded into a patchwork of policies that vary by product, timing and eligibility.

• Read more about Why Pharmaceutical Returns Policies Are Becoming More Complex

Three’s Company, Four’s Excluded: Structural Gaps in the FTC–Express Scripts Settlement

By Lari Harding, SVP, Industry Affairs & Strategic Partnerships, Inmar Intelligence The Federal Trade Commission (FTC) has proposed a consent order with Express Scripts (ESI), one of the nation’s largest pharmacy benefit managers (PBMs), to resolve allegations related to insulin pricing practices and broader competition concerns.

• Read more about Three’s Company, Four’s Excluded: Structural Gaps in the FTC–Express Scripts Settlement

Transform Sports Fan Data Into a Scalable Fan Engagement Solution

Modern sports organizations sit on a wealth of fan data, but data alone doesn’t create loyalty, sell tickets, or grow sponsorship revenue. What does? A fan engagement platform that turns insight into timely, relevant experiences across every touchpoint.

• Read more about Transform Sports Fan Data Into a Scalable Fan Engagement Solution

What the Latest Data Shows About Unsaleable Returns

Pharmaceutical returns are often treated as a routine task. Products expire, recalls happen and inventory is cleared out as needed. But recent data shows that unsaleable returns are more than an operational chore. They offer insight into financial performance, compliance risk and how well pharmacy operations are keeping up with a changing supply chain.

• Read more about What the Latest Data Shows About Unsaleable Returns

2026 NoLo Alcohol Report

Alcohol consumption continues to decline across key age groups, and more consumers are choosing no/low options throughout the year. What began as a spike driven only by Dry January is now supported by recurring seasonal demand, premium trade-ups, and sustained interest in value. Our 2026 NoLo Trends Report explores 3 trends influencing category growth and what they mean for planning in the year ahead.

• Read more about 2026 NoLo Alcohol Report